Chalise Som N, Sahib Taaliba A, Boyer Gregory A, Pathak Vikas
Pulmonary and Critical Care Medicine, Riverside Health System, Newport News, USA.
Emergency Medicine, Riverside Health System, Newport News, USA.
Cureus. 2022 Nov 6;14(11):e31158. doi: 10.7759/cureus.31158. eCollection 2022 Nov.
Many patients suffer shock in intensive care units (ICU). The majority of the patients with shock respond to standard treatment with vasopressors in addition to the treatment of underlying etiology. Some may not respond to vasopressors and have high mortality. To those patients who do not respond, methylene blue has been used in the past with some success. We present a case report on the use of methylene blue along with a brief literature review.
许多患者在重症监护病房(ICU)中会发生休克。大多数休克患者除了针对潜在病因进行治疗外,还会对使用血管加压药的标准治疗产生反应。有些患者可能对血管加压药无反应,且死亡率很高。对于那些无反应的患者,过去曾使用亚甲蓝并取得了一定成功。我们在此呈现一份关于亚甲蓝使用的病例报告,并进行简要的文献综述。